Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6Resectable Pancreatic Carcinoma 1Peritoneal Neoplasms 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Intraductal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Kidney Failure, Chronic 1Gastroparesis 1Cholangiocarcinoma 1Carcinoma, Acinar Cell 1

Interventions

Gemcitabine 33Cisplatin 28pembrolizumab 19durvalumab 17Oxaliplatin 16Fluorouracil 16Leucovorin 14Magnetic Resonance Spectroscopy 13Biopsy 10Specimen Handling 9lenvatinib 7Nivolumab 7Capecitabine 7Taxes 6Paclitaxel 6Irinotecan 6fludarabine 5Folfox protocol 5Drug Therapy 5Carboplatin 5Albumin-Bound Paclitaxel 5pemigatinib 4Ipilimumab 4Fluorodeoxyglucose F18 4Floxuridine 4Cyclophosphamide 4Bevacizumab 4130-nm albumin-bound paclitaxel 4tremelimumab 3olaparib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Pancreatectomy × 1 year × Clear all
NCT02757859 2026-05-29

WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer

Thomas Jefferson University

Phase NA Active not recruiting
845 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Carcinoma, Acinar Cell, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡